P26. Are we better at preventing PJK today? a comparison of incidence 5-7 years later
Han Jo Kim, MD1; Jingyan Yang, PhD1; Justin S. Smith, MD, PhD2; Munish C. Gupta, MD3; Peter G. Passias, MD4; Jeffrey L. Gum, MD5; Shay Bess, MD6; Christopher P. Ames, MD7; Christopher I. Shaffrey, MD8; Eric O. Klineberg, MD9; Renaud Lafage, MSc1; Frank J. Schwab, MD1; Virginie Lafage, PhD1; International Spine Study Group10
1Hospital for Special Surgery, New York, NY, US; 2UVA Health System, Charlottesville, VA, US; 3Washington University School of Medicine, St. Louis, MO, US; 4NY Spine Institute, NYU Langone Health, New York, NY, US; 5Norton Leatherman Spine Center, Louisville, KY, US; 6Denver, CO, US; 7University of California, San Francisco, San Francisco, CA, US; 8University of Virginia, Charlottesville, VA, US; 9UC, Davis School of Medicine, Sacramento, CA, US; 10Brighton, CO, US
FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
P28. Bone mineral density t-score is an independent predictor of significant blood loss in adult spinal deformity surgery
Andrew B. Harris, BS1; Varun Puvanesarajah, MD2; Micheal Raad, MD3; Corinna Zygourakis, MD4; A. Jay Khanna, MD5; Khaled M. Kebaish, MD6
1Johns Hopkins Hospital, Baltimore, MD, US; 2Johns Hopkins Medicine, Baltimore, MD, US; 3Baltimore, MD, US; 4Stanford Dept of Neurosurgery, Stanford, CA, US; 5Johns Hopkins Orthopaedic Surgery-- National Capital Region, Bethesda, MD, US; 6Johns Hopkins University, Baltimore, MD, US
FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.